4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Greenwich LifeSciences, Inc. (GLSI) operates in the Biotechnology industry and is headquartered in Stafford, United States. Its market capitalization is roughly $286 million. In the fiscal year ended 2025-12-31, GLSI reported $0M in revenue and ($19M) in net income.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($19M) | ($18M) | ($9M) | ($8M) |
| Net Income | ($19M) | ($17M) | ($9M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($6M) | ($8M) | ($4M) | ($4M) | ($3M) |
| Net Income | ($6M) | ($8M) | ($4M) | ($4M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $6M | $4M | $7M | $14M | — |
| Total Liabilities | $6M | $3M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GLSI viewer.
About TickerBase · Data methodology & sources